{"transactions":[{"id":2630305,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to buy)","published_at":"2021-07-19T17:41:23.000Z","date":"2021-07-15","kind":"disposition_to_issuer","acquired":false,"shares":41800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."}],"balance_after":0,"derivative":{"exercise_price":36.06,"underlying":"Common Stock","underlying_shares":41800},"source":{"system":"sec-edgar","filing":"0001562180-21-004987","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218021004987/primarydocument.xml","form_type":"4"}},{"id":2630304,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-19T17:41:23.000Z","date":"2021-07-15","kind":"disposition_to_issuer","acquired":false,"shares":22425,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."}],"balance_after":0,"derivative":{"exercise_price":8.76,"underlying":"Common Stock","underlying_shares":22425},"source":{"system":"sec-edgar","filing":"0001562180-21-004987","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218021004987/primarydocument.xml","form_type":"4"}},{"id":2630303,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-19T17:41:23.000Z","date":"2021-07-15","kind":"disposition_to_issuer","acquired":false,"shares":81939,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."}],"balance_after":0,"derivative":{"exercise_price":11.5,"underlying":"Common Stock","underlying_shares":81939},"source":{"system":"sec-edgar","filing":"0001562180-21-004987","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218021004987/primarydocument.xml","form_type":"4"}},{"id":2630302,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-19T17:41:23.000Z","date":"2021-07-15","kind":"disposition_to_issuer","acquired":false,"shares":58600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This Form 4 reports securities disposed of under the terms of the Agreement and Plan of Merger (the ''Agreement''), dated as of June 2, 2021, among Constellation Pharmaceuticals, Inc. (the \"Company\"), MorphoSys AG (\"Parent\") and MorphoSys Development Inc. (\"Purchaser\"), an indirect wholly owned subsidiary of Parent. Pursuant to the Agreement, on July 15, 2021 (the \"Effective Time\"), Purchaser merged with and into the Company, with the Company becoming a wholly owned subsidiary of Parent (the \"Merger\").  In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was converted into the right to receive $34.00 in cash, without interest and subject to any required withholding of taxes (the \"Merger Consideration\")."}],"balance_after":0,"derivative":{"exercise_price":35.5,"underlying":"Common Stock","underlying_shares":58600},"source":{"system":"sec-edgar","filing":"0001562180-21-004987","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218021004987/primarydocument.xml","form_type":"4"}},{"id":2849872,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-18T16:52:32.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":58600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 16, 2021, and the shares underlying the option vest in equal quarterly installments through February 16, 2025, subject to continued service."}],"balance_after":58600,"derivative":{"exercise_price":35.5,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":58600},"source":{"system":"sec-edgar","filing":"0001562180-21-001263","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218021001263/primarydocument.xml","form_type":"4"}},{"id":2902160,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-20T17:56:15.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":17203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022."}],"balance_after":81939,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":17203},"source":{"system":"sec-edgar","filing":"0001562180-21-000392","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218021000392/primarydocument.xml","form_type":"4"}},{"id":2902159,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-20T17:56:15.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":7203,"price":35.1088,"value":252888.6864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $35.00 to $35.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-21-000392","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218021000392/primarydocument.xml","form_type":"4"}},{"id":2902158,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-20T17:56:15.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":1227,"price":33.6936,"value":41342.0472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $33.56 to $33.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":7203,"source":{"system":"sec-edgar","filing":"0001562180-21-000392","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218021000392/primarydocument.xml","form_type":"4"}},{"id":2902157,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-20T17:56:15.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":8773,"price":33.0824,"value":290231.8952,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $32.51 to $33.505. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8430,"source":{"system":"sec-edgar","filing":"0001562180-21-000392","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218021000392/primarydocument.xml","form_type":"4"}},{"id":2902156,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-20T17:56:15.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":17203,"price":11.5,"value":197834.5,"ownership":{"direct":true},"balance_after":17203,"source":{"system":"sec-edgar","filing":"0001562180-21-000392","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218021000392/primarydocument.xml","form_type":"4"}},{"id":3157986,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-07T16:34:44.000Z","date":"2020-05-06","kind":"exercise","acquired":false,"shares":2467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on March 7, 2019. The shares underlying the option are scheduled to vest in equal quarterly installments through March 7, 2023."}],"balance_after":22425,"derivative":{"exercise_price":8.76,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":2467},"source":{"system":"sec-edgar","filing":"0001562180-20-003453","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003453/primarydocument.xml","form_type":"4"}},{"id":3157985,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-07T16:34:44.000Z","date":"2020-05-06","kind":"exercise","acquired":false,"shares":10099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022."}],"balance_after":99142,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":10099},"source":{"system":"sec-edgar","filing":"0001562180-20-003453","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003453/primarydocument.xml","form_type":"4"}},{"id":3157984,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-07T16:34:44.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":4744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022."}],"balance_after":109241,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":4744},"source":{"system":"sec-edgar","filing":"0001562180-20-003453","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003453/primarydocument.xml","form_type":"4"}},{"id":3157983,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-07T16:34:44.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":12566,"price":40.1,"value":503896.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $40.00 to $40.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-003453","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003453/primarydocument.xml","form_type":"4"}},{"id":3157982,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-07T16:34:44.000Z","date":"2020-05-06","kind":"exercise","acquired":true,"shares":2467,"price":8.76,"value":21610.92,"ownership":{"direct":true},"balance_after":12566,"source":{"system":"sec-edgar","filing":"0001562180-20-003453","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003453/primarydocument.xml","form_type":"4"}},{"id":3157981,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-07T16:34:44.000Z","date":"2020-05-06","kind":"exercise","acquired":true,"shares":10099,"price":11.5,"value":116138.5,"ownership":{"direct":true},"balance_after":10099,"source":{"system":"sec-edgar","filing":"0001562180-20-003453","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003453/primarydocument.xml","form_type":"4"}},{"id":3157980,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-07T16:34:44.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":4744,"price":40.0121,"value":189817.4024,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $40.00 to $40.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-003453","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003453/primarydocument.xml","form_type":"4"}},{"id":3157979,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-07T16:34:44.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":4744,"price":11.5,"value":54556.0,"ownership":{"direct":true},"balance_after":4744,"source":{"system":"sec-edgar","filing":"0001562180-20-003453","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003453/primarydocument.xml","form_type":"4"}},{"id":3167334,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-29T20:03:37.000Z","date":"2020-04-27","kind":"exercise","acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022."}],"balance_after":113985,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001562180-20-003207","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003207/primarydocument.xml","form_type":"4"}},{"id":3167333,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-29T20:03:37.000Z","date":"2020-04-27","kind":"sale","acquired":false,"shares":400,"price":40.13,"value":16052.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $40.03 to $40.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-003207","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003207/primarydocument.xml","form_type":"4"}},{"id":3167332,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-29T20:03:37.000Z","date":"2020-04-27","kind":"exercise","acquired":true,"shares":400,"price":11.5,"value":4600.0,"ownership":{"direct":true},"balance_after":400,"source":{"system":"sec-edgar","filing":"0001562180-20-003207","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003207/primarydocument.xml","form_type":"4"}},{"id":3171702,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-22T20:17:27.000Z","date":"2020-04-20","kind":"exercise","acquired":false,"shares":789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022."}],"balance_after":114385,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":789},"source":{"system":"sec-edgar","filing":"0001562180-20-003096","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003096/primarydocument.xml","form_type":"4"}},{"id":3171701,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-22T20:17:27.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":789,"price":33.6503,"value":26550.0867,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $35.13 to $35.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-003096","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003096/primarydocument.xml","form_type":"4"}},{"id":3171700,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-22T20:17:27.000Z","date":"2020-04-20","kind":"exercise","acquired":true,"shares":789,"price":11.5,"value":9073.5,"ownership":{"direct":true},"balance_after":789,"source":{"system":"sec-edgar","filing":"0001562180-20-003096","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003096/primarydocument.xml","form_type":"4"}},{"id":3173033,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-20T17:52:44.000Z","date":"2020-04-17","kind":"exercise","acquired":false,"shares":2300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022."}],"balance_after":115174,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":2300},"source":{"system":"sec-edgar","filing":"0001562180-20-003062","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003062/primarydocument.xml","form_type":"4"}},{"id":3173032,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-20T17:52:44.000Z","date":"2020-04-16","kind":"exercise","acquired":false,"shares":2998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022."}],"balance_after":117474,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":2998},"source":{"system":"sec-edgar","filing":"0001562180-20-003062","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003062/primarydocument.xml","form_type":"4"}},{"id":3173031,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-20T17:52:44.000Z","date":"2020-04-17","kind":"sale","acquired":false,"shares":2300,"price":35.191,"value":80939.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $35.00 to $35.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-003062","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003062/primarydocument.xml","form_type":"4"}},{"id":3173030,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-20T17:52:44.000Z","date":"2020-04-17","kind":"exercise","acquired":true,"shares":2300,"price":11.5,"value":26450.0,"ownership":{"direct":true},"balance_after":2300,"source":{"system":"sec-edgar","filing":"0001562180-20-003062","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003062/primarydocument.xml","form_type":"4"}},{"id":3173029,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-20T17:52:44.000Z","date":"2020-04-16","kind":"sale","acquired":false,"shares":1043,"price":34.0863,"value":35552.0109,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $33.845 to $34.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-003062","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003062/primarydocument.xml","form_type":"4"}},{"id":3173028,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-20T17:52:44.000Z","date":"2020-04-16","kind":"sale","acquired":false,"shares":1955,"price":33.2917,"value":65085.2735,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $32.835 to $33.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1043,"source":{"system":"sec-edgar","filing":"0001562180-20-003062","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003062/primarydocument.xml","form_type":"4"}},{"id":3173027,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-20T17:52:44.000Z","date":"2020-04-16","kind":"exercise","acquired":true,"shares":2998,"price":11.5,"value":34477.0,"ownership":{"direct":true},"balance_after":2998,"source":{"system":"sec-edgar","filing":"0001562180-20-003062","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020003062/primarydocument.xml","form_type":"4"}},{"id":3177841,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-13T16:56:46.000Z","date":"2020-04-09","kind":"exercise","acquired":false,"shares":635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 7, 2019. The shares underlying the option are scheduled to vest in equal quarterly installments through March 7, 2023."}],"balance_after":24892,"derivative":{"exercise_price":8.76,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":635},"source":{"system":"sec-edgar","filing":"0001562180-20-002991","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020002991/primarydocument.xml","form_type":"4"}},{"id":3177840,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-13T16:56:46.000Z","date":"2020-04-09","kind":"sale","acquired":false,"shares":635,"price":35.0177,"value":22236.2395,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $35.00 to $35.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-002991","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020002991/primarydocument.xml","form_type":"4"}},{"id":3177839,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-13T16:56:46.000Z","date":"2020-04-09","kind":"exercise","acquired":true,"shares":635,"price":8.76,"value":5562.6,"ownership":{"direct":true},"balance_after":635,"source":{"system":"sec-edgar","filing":"0001562180-20-002991","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020002991/primarydocument.xml","form_type":"4"}},{"id":3215642,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-11T16:11:33.000Z","date":"2020-03-09","kind":"exercise","acquired":false,"shares":617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on March 7, 2019, and the shares underlying the option vest in equal quarterly installments through March 7, 2023, subject to continued service."}],"balance_after":25527,"derivative":{"exercise_price":8.76,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":617},"source":{"system":"sec-edgar","filing":"0001562180-20-002396","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020002396/primarydocument.xml","form_type":"4"}},{"id":3215641,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-03-11T16:11:33.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":130,"price":32.9158,"value":4279.054,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $32.59 to $33.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-002396","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020002396/primarydocument.xml","form_type":"4"}},{"id":3215640,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-03-11T16:11:33.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":335,"price":32.0785,"value":10746.2975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $31.57 to $32.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":130,"source":{"system":"sec-edgar","filing":"0001562180-20-002396","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020002396/primarydocument.xml","form_type":"4"}},{"id":3215639,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-03-11T16:11:33.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":152,"price":31.1704,"value":4737.9008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.57 to $31.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":465,"source":{"system":"sec-edgar","filing":"0001562180-20-002396","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020002396/primarydocument.xml","form_type":"4"}},{"id":3215638,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-03-11T16:11:33.000Z","date":"2020-03-09","kind":"exercise","acquired":true,"shares":617,"price":8.76,"value":5404.92,"ownership":{"direct":true},"balance_after":617,"source":{"system":"sec-edgar","filing":"0001562180-20-002396","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020002396/primarydocument.xml","form_type":"4"}},{"id":3266703,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-18T16:53:30.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":41800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 14, 2020, and the shares underlying the option vest in equal quarterly installments through February 14, 2024, subject to continued service."}],"balance_after":41800,"derivative":{"exercise_price":36.06,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":41800},"source":{"system":"sec-edgar","filing":"0000899243-20-004897","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000089924320004897/doc4.xml","form_type":"4"}},{"id":3270485,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T17:09:12.000Z","date":"2020-02-13","kind":"exercise","acquired":false,"shares":1906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on March 7, 2019, and the shares underlying the option vest in equal quarterly installments through March 7, 2023, subject to continued service."}],"balance_after":26144,"derivative":{"exercise_price":8.76,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":1906},"source":{"system":"sec-edgar","filing":"0001562180-20-001250","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001250/primarydocument.xml","form_type":"4"}},{"id":3270484,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T17:09:12.000Z","date":"2020-02-13","kind":"exercise","acquired":false,"shares":2567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on July 19, 2018 and is scheduled to vest as to 25% of the shares underlying the option on July 16, 2019, with the remainder vesting in equal quarterly installments through July 16, 2022, subject to continued service."}],"balance_after":120472,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":2567},"source":{"system":"sec-edgar","filing":"0001562180-20-001250","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001250/primarydocument.xml","form_type":"4"}},{"id":3270483,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T17:09:12.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on July 19, 2018 and is scheduled to vest as to 25% of the shares underlying the option on July 16, 2019, with the remainder vesting in equal quarterly installments through July 16, 2022, subject to continued service."}],"balance_after":123039,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001562180-20-001250","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001250/primarydocument.xml","form_type":"4"}},{"id":3270482,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-14T17:09:12.000Z","date":"2020-02-13","kind":"sale","acquired":false,"shares":4473,"price":35.0679,"value":156858.7167,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $35.00 to $35.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-001250","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001250/primarydocument.xml","form_type":"4"}},{"id":3270481,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-14T17:09:12.000Z","date":"2020-02-13","kind":"exercise","acquired":true,"shares":2567,"price":11.5,"value":29520.5,"ownership":{"direct":true},"balance_after":4473,"source":{"system":"sec-edgar","filing":"0001562180-20-001250","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001250/primarydocument.xml","form_type":"4"}},{"id":3270480,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-14T17:09:12.000Z","date":"2020-02-13","kind":"exercise","acquired":true,"shares":1906,"price":8.76,"value":16696.56,"ownership":{"direct":true},"balance_after":1906,"source":{"system":"sec-edgar","filing":"0001562180-20-001250","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001250/primarydocument.xml","form_type":"4"}},{"id":3270479,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-14T17:09:12.000Z","date":"2020-02-12","kind":"sale","acquired":false,"shares":1500,"price":35.018,"value":52527.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $35.00 to $35.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-001250","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001250/primarydocument.xml","form_type":"4"}},{"id":3270478,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-14T17:09:12.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":1500,"price":11.5,"value":17250.0,"ownership":{"direct":true},"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001562180-20-001250","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001250/primarydocument.xml","form_type":"4"}},{"id":3273813,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-13T18:22:58.000Z","date":"2020-02-11","kind":"exercise","acquired":false,"shares":8550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on July 19, 2018 and is scheduled to vest as to 25% of the shares underlying the option on July 16, 2019, with the remainder vesting in equal quarterly installments through July 16, 2022, subject to continued service."}],"balance_after":124539,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":8550},"source":{"system":"sec-edgar","filing":"0001562180-20-001187","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001187/primarydocument.xml","form_type":"4/A","original_submission_date":"2020-02-12"}},{"id":3273812,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-13T18:22:58.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":12246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on July 19, 2018 and is scheduled to vest as to 25% of the shares underlying the option on July 16, 2019, with the remainder vesting in equal quarterly installments through July 16, 2022, subject to continued service."}],"balance_after":133089,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":12246},"source":{"system":"sec-edgar","filing":"0001562180-20-001187","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001187/primarydocument.xml","form_type":"4/A","original_submission_date":"2020-02-12"}},{"id":3273811,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-13T18:22:58.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":1850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 7, 2019, and the shares underlying the option vest in equal quarterly installments through March 7, 2023, subject to continued service."}],"balance_after":28050,"derivative":{"exercise_price":8.76,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":1850},"source":{"system":"sec-edgar","filing":"0001562180-20-001187","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001187/primarydocument.xml","form_type":"4/A","original_submission_date":"2020-02-12"}},{"id":3273810,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-13T18:22:58.000Z","date":"2020-02-11","kind":"sale","acquired":false,"shares":8550,"price":35.03,"value":299506.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $35.00 to $35.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-001187","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001187/primarydocument.xml","form_type":"4/A","original_submission_date":"2020-02-12"}},{"id":3273809,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-13T18:22:58.000Z","date":"2020-02-11","kind":"exercise","acquired":true,"shares":8550,"price":11.5,"value":98325.0,"ownership":{"direct":true},"balance_after":8550,"source":{"system":"sec-edgar","filing":"0001562180-20-001187","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001187/primarydocument.xml","form_type":"4/A","original_submission_date":"2020-02-12"}},{"id":3273808,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-13T18:22:58.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":14096,"price":33.51,"value":472356.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $32.37 to $35.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-001187","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001187/primarydocument.xml","form_type":"4/A","original_submission_date":"2020-02-12"}},{"id":3273807,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-13T18:22:58.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":12246,"price":11.5,"value":140829.0,"ownership":{"direct":true},"balance_after":14096,"source":{"system":"sec-edgar","filing":"0001562180-20-001187","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001187/primarydocument.xml","form_type":"4/A","original_submission_date":"2020-02-12"}},{"id":3273806,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-13T18:22:58.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":1850,"price":8.76,"value":16206.0,"ownership":{"direct":true},"balance_after":1850,"source":{"system":"sec-edgar","filing":"0001562180-20-001187","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001187/primarydocument.xml","form_type":"4/A","original_submission_date":"2020-02-12"}},{"id":3276882,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-12T17:36:14.000Z","date":"2020-02-11","kind":"exercise","acquired":false,"shares":8550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on July 19, 2018 and is scheduled to vest as to 25% of the shares underlying the option on July 16, 2019, with the remainder vesting in equal quarterly installments through July 16, 2022, subject to continued service."}],"balance_after":122689,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":8550},"source":{"system":"sec-edgar","filing":"0001562180-20-001122","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001122/primarydocument.xml","form_type":"4"}},{"id":3276881,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-12T17:36:14.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":14096,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on July 19, 2018 and is scheduled to vest as to 25% of the shares underlying the option on July 16, 2019, with the remainder vesting in equal quarterly installments through July 16, 2022, subject to continued service."}],"balance_after":131239,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":14096},"source":{"system":"sec-edgar","filing":"0001562180-20-001122","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001122/primarydocument.xml","form_type":"4"}},{"id":3276880,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-12T17:36:14.000Z","date":"2020-02-11","kind":"sale","acquired":false,"shares":8550,"price":35.03,"value":299506.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $35.00 to $35.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-001122","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001122/primarydocument.xml","form_type":"4"}},{"id":3276879,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-12T17:36:14.000Z","date":"2020-02-11","kind":"exercise","acquired":true,"shares":8550,"price":11.5,"value":98325.0,"ownership":{"direct":true},"balance_after":8550,"source":{"system":"sec-edgar","filing":"0001562180-20-001122","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001122/primarydocument.xml","form_type":"4"}},{"id":3276878,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-12T17:36:14.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":14096,"price":33.51,"value":472356.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $32.37 to $35.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-001122","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001122/primarydocument.xml","form_type":"4"}},{"id":3276877,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-12T17:36:14.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":14096,"price":11.5,"value":162104.0,"ownership":{"direct":true},"balance_after":14096,"source":{"system":"sec-edgar","filing":"0001562180-20-001122","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000156218020001122/primarydocument.xml","form_type":"4"}},{"id":3604028,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-08T16:51:48.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":29900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 7, 2019, and the shares underlying the option vest in equal quarterly installments through March 7, 2023, subject to continued service."}],"balance_after":29900,"derivative":{"exercise_price":8.76,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":29900},"source":{"system":"sec-edgar","filing":"0000899243-19-006922","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000089924319006922/doc4.xml","form_type":"4"}},{"id":3863629,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-20T17:42:07.000Z","date":"2018-07-19","kind":"grant","acquired":true,"shares":145335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 19, 2018 and is scheduled to vest as to 25% of the shares underlying the option on July 16, 2019, with the remainder vesting in equal quarterly installments through July 16, 2022, subject to continued service."}],"balance_after":145335,"derivative":{"exercise_price":11.5,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":145335},"source":{"system":"sec-edgar","filing":"0000899243-18-020284","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437152/000089924318020284/doc4.xml","form_type":"4"}},{"id":3885387,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer and GC"}}],"security":"Stock Options, right to buy","published_at":"2018-06-22T15:16:37.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":173150,"price":5.65,"value":978297.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018.  Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, and vests over three years with one-third of the award vesting on March 2, 2019 and the balance vesting in equal quarterly installments thereafter."}],"balance_after":173150,"derivative":{"exercise_price":5.65,"exercise_date":"2019-03-02","expiration_date":"2028-03-02","underlying":"Common Stock","underlying_shares":173150},"source":{"system":"sec-edgar","filing":"0001288123-18-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000128812318000007/primary_doc.xml","form_type":"4"}},{"id":4132154,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2017-12-14T21:14:27.000Z","date":"2017-12-12","kind":"sale","acquired":false,"shares":8358,"price":3.4603,"value":28921.1874,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents sales of shares sold solely to cover Federal , state and local tax on withholding requirements on the restricted shares settled and were sold at prices ranging between $3.495 and $3.44 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents sales of shares sold solely to cover Federal , state and local tax on withholding requirements on the restricted shares settled and were sold at prices ranging between $3.495 and $3.44 per share."}],"balance_after":101521,"source":{"system":"sec-edgar","filing":"0001288123-17-000040","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000128812317000040/primary_doc.xml","form_type":"4"}},{"id":4132153,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2017-12-14T21:14:27.000Z","date":"2017-10-09","kind":"grant","acquired":true,"shares":24824,"price":3.59,"value":89118.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents settlement of restricted shares awarded on July 1, 2015."}],"balance_after":109879,"source":{"system":"sec-edgar","filing":"0001288123-17-000040","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000128812317000040/primary_doc.xml","form_type":"4"}},{"id":4348109,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2017-04-21T20:13:41.000Z","date":"2017-04-19","kind":"disposition_to_issuer","acquired":true,"shares":8055,"price":3.39,"value":27306.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents exclusively, shares withheld by Agenus Inc. in respect of payment of the withholding tax liability upon the vesting of the restricted shares."}],"balance_after":85055,"source":{"system":"sec-edgar","filing":"0001288123-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000128812317000022/primary_doc.xml","form_type":"4"}},{"id":4348108,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2017-04-21T20:13:41.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":24822,"price":3.39,"value":84146.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents settlement of vested restricted shares granted on July 1, 2015."}],"balance_after":93110,"source":{"system":"sec-edgar","filing":"0001288123-17-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000128812317000022/primary_doc.xml","form_type":"4"}},{"id":4362496,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option, Right to Buy","published_at":"2017-04-04T22:31:42.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":162500,"price":3.77,"value":612625.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest one-third on the one-year anniversary of the grant date with the remainder vesting in equal quarterly installments provided the executive maintains a service relationship with the Company through each vesting date."}],"balance_after":162500,"derivative":{"exercise_price":3.77,"exercise_date":"2018-03-31","expiration_date":"2027-03-31","underlying":"Common Stock","underlying_shares":162500},"source":{"system":"sec-edgar","filing":"0001288123-17-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000128812317000010/primary_doc.xml","form_type":"4"}},{"id":4599200,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":137239,"kind":"person","name":"Valentine Karen","position":1,"cik":"0001437152","reported_name":"Valentine Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option, right to buy","published_at":"2016-09-20T20:05:41.000Z","date":"2016-09-16","kind":"grant","acquired":true,"shares":2083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Inventive Plan, and vests in one installment on the one-year anniversary of the grant date."}],"balance_after":2083,"derivative":{"exercise_price":6.77,"exercise_date":"2017-09-16","expiration_date":"2026-09-16","underlying":"Common Stock","underlying_shares":2083},"source":{"system":"sec-edgar","filing":"0000899243-16-029402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000089924316029402/doc4.xml","form_type":"4"}}]}